Annual Total Debt
$1.10 B
+$2.36 M+0.22%
31 December 2023
Summary:
BioMarin Pharmaceutical annual total debt is currently $1.10 billion, with the most recent change of +$2.36 million (+0.22%) on 31 December 2023. During the last 3 years, it has risen by +$6.21 million (+0.57%). BMRN annual total debt is now -6.70% below its all-time high of $1.17 billion, reached on 31 December 2017.BMRN Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$602.69 M
-$496.95 M-45.19%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly total debt is currently $602.69 million, with the most recent change of -$496.95 million (-45.19%) on 30 September 2024. Over the past year, it has dropped by -$493.06 million (-45.00%). BMRN quarterly total debt is now -58.70% below its all-time high of $1.46 billion, reached on 30 September 2020.BMRN Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -45.0% |
| 3 y3 years | +0.6% | -44.7% |
| 5 y5 years | +27.6% | -29.8% |
BMRN Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +0.6% | -45.2% | at low |
| 5 y | 5 years | at high | +27.6% | -58.7% | at low |
| alltime | all time | -6.7% | -58.7% |
BioMarin Pharmaceutical Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $602.69 M(-45.2%) |
| June 2024 | - | $1.10 B(+0.3%) |
| Mar 2024 | - | $1.10 B(+0.1%) |
| Dec 2023 | $1.10 B(+0.2%) | $1.10 B(+0.0%) |
| Sept 2023 | - | $1.10 B(+0.2%) |
| June 2023 | - | $1.09 B(+0.0%) |
| Mar 2023 | - | $1.09 B(-0.0%) |
| Dec 2022 | $1.09 B(+0.4%) | $1.09 B(+0.2%) |
| Sept 2022 | - | $1.09 B(-0.0%) |
| June 2022 | - | $1.09 B(+0.1%) |
| Mar 2022 | - | $1.09 B(+0.1%) |
| Dec 2021 | $1.09 B(+0.2%) | $1.09 B(+0.2%) |
| Sept 2021 | - | $1.09 B(-0.0%) |
| June 2021 | - | $1.09 B(+0.1%) |
| Mar 2021 | - | $1.09 B(+0.0%) |
| Dec 2020 | $1.09 B(+26.6%) | $1.09 B(-25.5%) |
| Sept 2020 | - | $1.46 B(+0.3%) |
| June 2020 | - | $1.45 B(+68.5%) |
| Mar 2020 | - | $863.08 M(+0.5%) |
| Dec 2019 | $858.82 M(+3.4%) | $858.82 M(+0.6%) |
| Sept 2019 | - | $853.84 M(+0.5%) |
| June 2019 | - | $849.33 M(+0.6%) |
| Mar 2019 | - | $843.98 M(+1.6%) |
| Dec 2018 | $830.42 M(-29.3%) | $830.42 M(-30.8%) |
| Sept 2018 | - | $1.20 B(+0.7%) |
| June 2018 | - | $1.19 B(+0.7%) |
| Mar 2018 | - | $1.18 B(+0.7%) |
| Dec 2017 | $1.17 B(+71.9%) | $1.17 B(+0.7%) |
| Sept 2017 | - | $1.17 B(+72.4%) |
| June 2017 | - | $676.21 M(-2.1%) |
| Mar 2017 | - | $690.93 M(+1.1%) |
| Dec 2016 | $683.24 M(+3.2%) | $683.24 M(+1.1%) |
| Sept 2016 | - | $675.64 M(+0.8%) |
| June 2016 | - | $670.11 M(+0.3%) |
| Mar 2016 | - | $668.01 M(+0.9%) |
| Dec 2015 | $662.29 M(+3.0%) | $662.29 M(-0.8%) |
| Sept 2015 | - | $667.79 M(+1.0%) |
| June 2015 | - | $661.49 M(+0.9%) |
| Mar 2015 | - | $655.49 M(+2.0%) |
| Dec 2014 | $642.90 M(-1.9%) | $642.90 M(-2.1%) |
| Sept 2014 | - | $656.88 M(+0.9%) |
| June 2014 | - | $650.87 M(-1.6%) |
| Mar 2014 | - | $661.42 M(+0.9%) |
| Dec 2013 | $655.57 M(+88.3%) | $655.57 M(+737.1%) |
| Sept 2013 | - | $78.31 M(-28.7%) |
| June 2013 | - | $109.82 M(-0.0%) |
| Mar 2013 | - | $109.85 M(-68.5%) |
| Dec 2012 | $348.22 M(-0.0%) | $348.22 M(-0.0%) |
| Sept 2012 | - | $348.30 M(-0.0%) |
| June 2012 | - | $348.31 M(-0.0%) |
| Mar 2012 | - | $348.33 M(-0.0%) |
| Dec 2011 | $348.33 M | $348.33 M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $348.34 M(-7.7%) |
| June 2011 | - | $377.52 M(-0.0%) |
| Mar 2011 | - | $377.52 M(0.0%) |
| Dec 2010 | $377.52 M(-24.1%) | $377.52 M(-29.2%) |
| Sept 2010 | - | $533.41 M(+2.3%) |
| June 2010 | - | $521.24 M(-0.7%) |
| Mar 2010 | - | $524.86 M(+5.6%) |
| Dec 2009 | $497.08 M(-12.5%) | $497.08 M(0.0%) |
| Sept 2009 | - | $497.08 M(0.0%) |
| June 2009 | - | $497.08 M(-12.4%) |
| Mar 2009 | - | $567.40 M(-0.1%) |
| Dec 2008 | $567.82 M(+14.2%) | $567.82 M(+14.2%) |
| Sept 2008 | - | $497.24 M(-1.2%) |
| June 2008 | - | $503.06 M(-0.1%) |
| Mar 2008 | - | $503.37 M(+1.2%) |
| Dec 2007 | $497.38 M(+115.6%) | $497.38 M(-12.9%) |
| Sept 2007 | - | $570.87 M(-0.1%) |
| June 2007 | - | $571.49 M(+131.2%) |
| Mar 2007 | - | $247.23 M(+7.2%) |
| Dec 2006 | $230.73 M(+2.9%) | $230.73 M(-23.1%) |
| Sept 2006 | - | $299.87 M(-19.8%) |
| June 2006 | - | $374.02 M(-5.3%) |
| Mar 2006 | - | $394.88 M(+76.1%) |
| Dec 2005 | $224.26 M(-17.2%) | $224.26 M(-0.8%) |
| Sept 2005 | - | $226.14 M(-0.9%) |
| June 2005 | - | $228.11 M(+34.5%) |
| Mar 2005 | - | $169.66 M(-37.4%) |
| Dec 2004 | $270.84 M(+116.7%) | $270.84 M(+0.0%) |
| Sept 2004 | - | $270.81 M(+44.8%) |
| June 2004 | - | $187.01 M(+49.6%) |
| Mar 2004 | - | $125.00 M(0.0%) |
| Dec 2003 | $125.00 M(>+9900.0%) | $125.00 M(0.0%) |
| Sept 2003 | - | $125.00 M(0.0%) |
| June 2003 | - | $125.00 M(>+9900.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2002 | - | $2.91 M(>+9900.0%) |
| June 2002 | - | $0.00(-100.0%) |
| Mar 2002 | - | $5.22 M(-6.0%) |
| Dec 2001 | $5.55 M(+6589.2%) | $5.55 M(+2203.7%) |
| Sept 2001 | - | $241.00 K(-18.6%) |
| June 2001 | - | $296.00 K(+289.5%) |
| Mar 2001 | - | $76.00 K(-8.4%) |
| Dec 2000 | $83.00 K(-25.2%) | $83.00 K(-8.8%) |
| Sept 2000 | - | $91.00 K(-6.2%) |
| June 2000 | - | $97.00 K(-5.8%) |
| Mar 2000 | - | $103.00 K(-7.2%) |
| Dec 1999 | $111.00 K(+11.0%) | $111.00 K(+11.0%) |
| Sept 1999 | - | $100.00 K(-99.6%) |
| June 1999 | - | $26.10 M(>+9900.0%) |
| Mar 1999 | - | $100.00 K |
| Dec 1998 | $100.00 K | - |
FAQ
- What is BioMarin Pharmaceutical annual total debt?
- What is the all time high annual total debt for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly total debt?
- What is the all time high quarterly total debt for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly total debt year-on-year change?
What is BioMarin Pharmaceutical annual total debt?
The current annual total debt of BMRN is $1.10 B
What is the all time high annual total debt for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual total debt is $1.17 B
What is BioMarin Pharmaceutical quarterly total debt?
The current quarterly total debt of BMRN is $602.69 M
What is the all time high quarterly total debt for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly total debt is $1.46 B
What is BioMarin Pharmaceutical quarterly total debt year-on-year change?
Over the past year, BMRN quarterly total debt has changed by -$493.06 M (-45.00%)